科研级 Bermekimab (贝迈奇单抗 ), Anti-IL1A Recombinant Antibody, Research Grade Bermekimab
Molecular Name
Bermekimab
Size
1mg, 5mg
CAS Number
1401965-15-8
Isotype
IgG1 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
IL1A[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Bermekimab[1] (MABp1, trade name Xilonix) is a human monoclonal antibody of IgG1k isotype targeting Interleukin 1 alpha (IL1A). As of March 2017, bermekimab is in phase III clinical trials as an immunotherapy for colorectal cancer and as of September 2018 in phase II clinical trials for the treatment of atopic dermatitis.